Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
European Lead Extraction Controlled Registry (ELECTRa) is the first large, prospective, multi-centre, European-controlledregistry of consecutive patients undergoing Transvenous Lead Extraction (TLE) procedures. Recruitment of patients began in November2012 and ended in May 2014 with a follow-up phase at one year. Preliminary results on TLE in Europe was presented during the 2014 ESC Congress in Barcelona, the EHRA EUROPACE - CARDIOSTIM 2015 meeting in Milan, and at the 2015 ESC Congress in London.
More details here.
This is a centre-based registry, initiated in collaboration with the EURObservational Research Programme. It aims at enrolling 750 patients.The objectives are to describe the clinical epidemiology of patients undergoing an EHAFA procedure, diagnostic/therapeutic processes applied in these patients across Europe, short and long-term outcomes and their predictors.The centres have just started enrolling patients in this registry. All centres performing EHAFA procedures are welcome to join.
Early Comprehensive Atrial Fibrillation Stroke Prevention Trial (EAST) is a European, investigator-initiated study jointly conducted by AFNET and EHRA. The trial is supported by a unique partnership including Sanofi Aventis and St Jude Medical, receiving further funding from the German Ministry of Education and Research (BMBF) through the German Centre for Heart Research (DZHK).
Its aims are to determine whether early, standardised, rhythm control intervention can help prevent adverse cardiovascular outcomes associated with atrial fibrillation, including stroke and death. At the end of 2015, over 2 350 patients were enrolled in 11 European countries. We expect to continue enrolment until early 2016.
For more information please contact : email@example.com
The primary objective of this survey is to describe current European practice based on a representative sampling in 13 countries. More details here
© 2017 European Society of Cardiology. All rights reserved